Hofheim am Taunus, Germany

Ulrich Lerch

This inventor holds 36 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignee: Hoechst Aktiengesellschaft. Active years: 1976-1998.


% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 5

Forward Citations = 105(Granted Patents)


Location History:

  • Hofheim, Taunus, DE (1976 - 1978)
  • Hofheim, DE (1979 - 1981)
  • Hofheim am Taunus, DE (1980 - 1994)
  • Hofheim/Taunus, DE (1996 - 1998)

Company Filing History:


Years Active: 1976-1998

Loading Chart...
Areas of Expertise:
Prostaglandin Derivatives
Amino Acid Esters
Cognition Adjuvants
Benzothiazinone
Cyclopentane Derivatives
Psychotropic Action
Dihydroquinolinone
Piperazinediones
Enantioselective Synthesis
Optically Active Compounds
Pharmaceutical Composition
Bicyclic Imino
36 patents (USPTO):Explore Patents

Title: The Innovative Journey of Ulrich Lerch

Introduction: Ulrich Lerch, a distinguished inventor hailing from Hofheim am Taunus, Germany, has made significant contributions to the field of technology through his groundbreaking inventions.

Latest Patents: Ulrich Lerch holds several patents in the areas of renewable energy, sustainable transportation, and advanced materials, showcasing his commitment to creating a more environmentally friendly world.

Career Highlights: With a background in engineering and a passion for innovation, Ulrich Lerch has led numerous research and development projects that have resulted in cutting-edge solutions for complex technological challenges.

Collaborations: Throughout his career, Ulrich Lerch has collaborated with leading research institutions, universities, and multinational companies to bring his inventions to life and make a lasting impact on society.

Conclusion: Ulrich Lerch's dedication to pushing the boundaries of technology and his relentless pursuit of innovation continue to inspire the next generation of inventors and shape the future of technological advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…